1. Abstract, Introduction: I wonder whether you can tell anything about true preventive effects of an intervention within a 6-month time horizon. Couldn't it be that a depression is not prevented but rather the onset delayed? As the primary outcome is defined as depressive and anxiety symptoms, the aim of the study might be rephrased to reducing depressive and anxiety symptom severity. 2. Abstract, Methods: Could you provide information about the difference between intervention group A and B already in the abstract? 3. Methods and analysis, Participants: The authors state that the target population are healthy nurses. However, the in-and exclusion criteria do not define any criteria with regard to depressive and anxiety symptoms. This should be clarified. 4. Methods and analysis, Control group: I assume that participants have unrestricted access to TAU as well? 5. Methods and analysis, Sample size calculation: In the abstract and procedures, it is stated that 360 participants will be randomized to each of the 3 groups. In the paragraph on the sample size calculation, only 338 participants per group are mentioned. I assume the 360 is corrected for drop-out. However, this should be explained in the section on the sample size calculation. 6. Methods and analysis, Randomization: It is stated that stratified permuted-block randomization will be used. However, what block sizes will be used? Are block sizes fixed or do they vary? 7. Methods and analysis, Statistical methods, Clinical efficacy: The authors state that analyses will follow the intention-to-treat principle by using mixed models. However, effect sizes (Cohen's d) are only based on study completers' data indicating that the intention-to-treat principle is not applied. The authors might want to consider any form of imputation techniques for the calculation of effect sizes. 8. Methods and analysis, Statistical methods, Clinical efficacy: I assume that p-values will be set at alpha = 0.05? 8. Ethics and Dissemination, Strength and limitations: The authors state that the greatest strength of the study is its focus on the effect of smartphone programs on improving subthreshold depressive symptoms. However, in the in-/ exclusion criteria no lower and upper limit is defined with regard to depressive symptom severity. It might happen that healthy or already depressed nurses, respectively, enter the study. Thus, the authors should be more careful in describing the strength of the study and clarify the actual target group as well as target condition.
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GENERAL COMMENTS
This manuscript presents a protocol for a three-arm randomized controlled trial (RCT) examining the effects of newly developed smartphone-based Internet cognitive behavioural therapy (iCBT) programs on preventing depressive and anxiety symptoms as primary outcomes at 3-and 6-month follow-ups among hospital nurses in Vietnam. I credit the authors on the exploration of this important area. The paper is well-conceptualised and makes a useful contribution to the literature. There are some areas where clarification and revision are needed. My major concern is the planned aim of determining effectiveness in terms of adherence of the two smartphone apps due solely to the freedom of choice in the app, but the app content and presumably many elements of UX are potentially confounders or contaminants to this aim. This reviewer would also recommend clearly laying out the hypotheses as they pertain to the specific outcomes.
There is an assumed 100% response rate of eligible nurses. This appears surprising. Similarly based on the sample size calculation (which does not account for dropout-a major factor!) only 66 individuals would be able to decline or withdraw and still meet adequate power. This requires attention and explanation. The authors state both in the title and throughout the paper that the primary outcomes are depression and anxiety. This is somewhat inaccurate and should be better expressed as "symptoms". The abstract should make more specific mention of the basic content of the 3 arms (ie CBT-based, Stress-based, waitlist).
"access to internet via" was an inclusion criteria but not the specific ownership of such a device. Is it likely that those using someone elses device would be able to complete the trial equally? How are assessments delivered and data collected? Statistical analysis section requires more elaboration making mention of covariance matrix, treatment of imbalance between groups, and how missing data will be handled (certainly MMRM is robust but there is still a need for discussion of the quality of missingness)
Minor comments At times the language felt awkward (at least to this reviewer), for instance: Page 7 line 3: perhaps add parentheses: (including two different intervention groups) Page 9 line 12: "hearing from and discussion with" requires comma usage but might eb better expressed as "consultation with" Page 15 line 30: the use of "each three-arm" might be better expressed as "one of the three trial arms" Page 14 line 8: "Presentism" should be "presenteeism"
VERSION 1 -AUTHOR RESPONSE
Reviewer ( The MS describes the protocol for a 3-armed RCT to evaluate the effectiveness of two versions of a smartphone-based stress management program on preventing depression and anxiety among hospital nurses in Vietnam. The protocol is well written and the rationale for the trial is clear. However, some points could be addressed in a revision:
1. Abstract, Introduction: I wonder whether you can tell anything about true preventive effects of an intervention within a 6-month time horizon. Couldn't it be that a depression is not prevented but rather the onset delayed? As the primary outcome is defined as depressive and anxiety symptoms, the aim of the study might be rephrased to reducing depressive and anxiety symptom severity.
Response:
Thank you for your positive comments and useful advices. As you pointed out, we agree that using the terminology of "depression and anxiety" was not appropriate. Now we replaced the words "depression and anxiety" with "depressive and anxiety symptom severity".
2. Abstract, Methods: Could you provide information about the difference between intervention group A and B already in the abstract?
Now we have revised the sentence in the Methods (line 10 to 13 on page 3) as follows;
"Participants who fulfil the eligibility criteria will be randomly allocated to the a free-choice, multimodule stress management (intervention group A, n = 360), the Internet cognitive behavioral therapy (iCBT), i.e., fixed-order, stress management (intervention group B, n = 360), or a treatment as usual control group (n = 360)."
3. Methods and analysis, Participants: The authors state that the target population are healthy nurses. However, the in-and exclusion criteria do not define any criteria with regard to depressive and anxiety symptoms. This should be clarified.
As you pointed out, we agree that using the terminology of "healthy nurses" was not appropriate. Now, we removed the word "healthy".
4. Methods and analysis, Control group: I assume that participants have unrestricted access to TAU as well?
As you pointed out, all participants in this study have unrestricted access to TAU. Now, we have revised the sentence in the Methods and Analysis (line 29 to 30 on page 12) as follows as follows;
"Participants both in the intervention group and the control group will be able to use an internal employee assistance program service as treatment as usual."
5. Methods and analysis, Sample size calculation: In the abstract and procedures, it is stated that 360 participants will be randomized to each of the 3 groups. In the paragraph on the sample size calculation, only 338 participants per group are mentioned. I assume the 360 is corrected for drop-out. However, this should be explained in the section on the sample size calculation.
Response:
We apologize for the unclear description about that. Now, we revised the sentence about sample size calculation in the Methods and Analysis (line 31 to 34 on page 15) as follows; "To detect a small effect size (i.e., 0.25) or more at an alpha error rate of 0.05 and a beta error rate of 0.15, the estimated sample size was 289 participants in each group. With an anticipated dropout rate of 25 %, the necessary sample size was 361 participants per arm."
6. Methods and analysis, Randomization: It is stated that stratified permuted-block randomization will be used. However, what block sizes will be used? Are block sizes fixed or do they vary?
We added an underlined sentence in the Methods and Analysis (line 4 on page 16) as follows;
"The block sizes of this study will be fixed to three."
7. Methods and analysis, Statistical methods, Clinical efficacy: The authors state that analyses will follow the intention-to-treat principle by using mixed models. However, effect sizes (Cohen's d) are only based on study completers' data indicating that the intention-to-treat principle is not applied. The authors might want to consider any form of imputation techniques for the calculation of effect sizes. Now, we added underlined sentences about calculation of estimated effect size using MIXED procedure by the SPSS in the Methods and Analysis (line 22 to 25 on page 16) as follows;
"The effect size indicators are two-fold. We will estimate a regression coefficient for a group (each of the two intervention groups vs. the control group) x time (baseline and two follow-ups) interaction using the MIXED procedure, that will be converted an effect size by dividing by a pooled SD at baseline and at follow-ups."
8. Methods and analysis, Statistical methods, Clinical efficacy: I assume that p-values will be set at alpha = 0.05?
As you pointed out, we will set the statistical significance level at 0.05 in this study. We added an underlined sentence in the Methods and Analysis (line 26 to 27 on page 16) as follows;
"The level of statistical significance for all analyses in this study will be set at 0.05 (two-tailed), and 95% CIs will be calculated."
8. Ethics and Dissemination, Strength and limitations: The authors state that the greatest strength of the study is its focus on the effect of smartphone programs on improving subthreshold depressive symptoms. However, in the in-/ exclusion criteria no lower and upper limit is defined with regard to depressive symptom severity. It might happen that healthy or already depressed nurses, respectively, enter the study. Thus, the authors should be more careful in describing the strength of the study and clarify the actual target group as well as target condition.
As you pointed out above, we also agree that using the terminology of "healthy nurses" was not appropriate. Again, we removed the word "healthy".
Reviewer: 2
Reviewer Name: Dr Mark Deady Institution and Country: UNSW, Australia
Please state any competing interests or state 'None declared': None Please leave your comments for the authors below This manuscript presents a protocol for a three-arm randomized controlled trial (RCT) examining the effects of newly developed smartphone-based Internet cognitive behavioural therapy (iCBT) programs on preventing depressive and anxiety symptoms as primary outcomes at 3-and 6-month follow-ups among hospital nurses in Vietnam. I credit the authors on the exploration of this important area. The paper is well-conceptualised and makes a useful contribution to the literature. There are some areas where clarification and revision are needed.
My major concern is the planned aim of determining effectiveness in terms of adherence of the two smartphone apps due solely to the freedom of choice in the app, but the app content and presumably many elements of UX are potentially confounders or contaminants to this aim.
Thank you for your positive comments and useful advices. As you pointed out, we agree that there are some differences between the two intervention programs, while these programs include same CBT components. Now, we added the sentences to clarify this point in the Methods and Analysis (line 12 to 16 on page 15) and in the Strength and limitation (line 10 to 11 on page 19) as follows;
"It is technically difficult to make the content of the two intervention programs identical; the adaptation and modification process following the consultation with nurses in Vietnam make it more difficult. However, we still use the same CBT components (i.e., behavioral activation, cognitive restructuring, and problem solving) in both of the programs, keeping 50% of the content overlapping (see Table 1 )."
"Third, a slight difference in the content between the two intervention programs may be also a limitation in comparing the adherence between the free-choice program and the fixed-order program."
This reviewer would also recommend clearly laying out the hypotheses as they pertain to the specific outcomes.
Now, we have added three hypotheses in this study in the Objectives (line 3 to 12 on page 7) as follows;
H1: The newly developed smartphone-based multi-module stress management intervention programs will significantly improve the primary outcomes (i.e., depressive and anxiety symptoms) among participants in the intervention groups compared with participants in the control group.
H2: The newly developed smartphone-based multi-module stress management intervention programs will significantly improve the secondary outcomes (i.e. work engagement, work performance, stress symptoms, psychosocial work environment, and health-related QOL) among participants in the intervention groups compared with participants in the control group.
H3: Participants will show significantly better adherence (i.e., completion rate of the program) to the free-choice program than the fixed-sequence program.
There is an assumed 100% response rate of eligible nurses. This appears surprising. Similarly based on the sample size calculation (which does not account for dropout-a major factor!) only 66 individuals would be able to decline or withdraw and still meet adequate power. This requires attention and explanation.
This matter has been also pointed out by Reviewer 1. We apologize for unclear description about that. Now, we revised the sentence about sample size calculation in the Methods and Analysis (line 31 to 34 on page 15) as follows; "To detect a small effect size (i.e., 0.25) or more at an alpha error rate of 0.05 and a beta error rate of 0.15, the estimated sample size was 289 participants in each group. With an anticipated dropout rate of 25 %, the necessary sample size was 361 participants per arm."
